Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Would the Prof have this in his Twitter handle?!!
GLA
I think the clever people that got you a special dividend will have sorted that out!
Just your paper profits? Kiss goodbye to 250p
Expected Fri
I was watching it intently all day every week. Any mm games like dips were bought into. Was NT many times in the day. They drop to scoop up shares knowing what’s coming. But with free float so short they have to increase the price.
Was 49p last week at start. A large premium at 49.6 showed me it was going to be a big week.
I am expecting it at latest possible time - so Friday. Don’t get your hopes up for tmrw. We rise and all good. We fall and all good as the dip will be savagely bought into knowing what’s coming. People have waited now.
I’m expecting news on Friday at latest possible point.
Red day means more buying opportunity if that’s the case. Look at the drop to 71 was savaged - smart money loads up whilst there is an element of fear and weak holders exit missing the real gains.
When this moves it moves up fast and has been NT often.
Relax - nothing has changed. We’ve known about other tests being developed since last summer. Nothings changed other than BRH now in the mix and we have a global issue. The thought of another juicy dividend and capital growth is the holy grail!
The other aspect is this test is believed to cover all variants or at least that’s what seems to be purported.
I agree - which company has more share price growth potential - based on comparables we can get to 10x from here.
1. We’ve always been under the radar.
2. There is plenty for all.
3. Avct still need to prove this on a bigger clinical sample but expect the results to be similar.
4. A high quality fast test has a place in a global market - just like we have multiple vaccines.
5. The price rose sharply after a small drop on the day of the Avct initial data.
6. The market cap vs peers is just so out hence scope for plenty of price rises to come.
7. This test is 5 mins or less. The LFT are about 10-15
8. This is a British (Yorkshire) based test too that has helped!
Expecting this to bag multiple times from here.
Bought in at 1.8 and 2.8 based on track record of BOD and TR1 - yes highly speculative - risk vs reward
Q&A - aggressive approach to capacity. Did look at facility in Dundee. CK felt within timeframe it was difficult. So looked at efficiency within existing site. Get equipment in Alva and ramped up and don't need more Operational or QA managers so more practical and cost effective.
Q&A 2 - Can you be clear on ELISA - expand or switch to LFT?
Without question a greater emphasis on LFT - market feedback was the demand needs a rapid antigen test
Q&A 3 - When expect generating revenue for CD4?
Small so far - look at finncap research for expectation of delivering revenue. Already received orders from 6 countries. Expect others to come through from new year.
Selling price = 4$ and 70% margin for CD4. Expect cost of goods to be reduced by 50%
No its not ended yet - very positive
Yeah Q&A
The govt has placed an initial order with Abingdon of 1m - this is just an initial order. Expecting more to come.
RTC tests supplied to government - finncap estimate good guide
Other tests (3rd party) - there will be extra profit share mechanism ultimately linked to price achieved by 3rd party
Want to actively looking into testing for TB
NOT Planning on raising on money via a placing.
Antigen opportunity is massive for us - good position both short and long term. Expect significantly better second half